We demonstrated that METTL3 is markedly induced in AKI, and its mediated m6A modification increases SREBP1c mRNA stability through binding to IGF2BP3, leading to mitochondrial energy metabolism dysfunction in RTECs. Here, METTL3 is linked to acute kidney injury.